| Malignant Rectal Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 118show all (up to 200) |
|---|
| → investigated in trials for | Capecitabinesmall_molecule 129 trials (48 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 129 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 115 trials (40 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 115 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 86 trials (17 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 86 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 54 trials (9 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 53 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 41 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 31 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | CAPOX Regimen 23 trials (14 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 20 trials (13 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 18 trials (12 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 15 trials (9 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Rectal Neoplasm | 9 | Observed | clinicaltrials | graph → |